RAS Mutations Are the Predominant Molecular Alteration in Poorly Differentiated Thyroid Carcinomas and Bear Prognostic Impact

  • Marco Volante
    Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
  • Ida Rapa
    Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
  • Manoj Gandhi
    Department of Pathology (M.G., Y.E.N.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260
  • Gianni Bussolati
    Department of Biomedical Sciences and Human Oncology (G.B.), University of Turin, 10126 Turin, Italy
  • Daniela Giachino
    Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
  • Mauro Papotti
    Department of Clinical and Biological Sciences (M.V., I.R., D.G., M.P.), San Luigi Hospital, 10043 Orbassano, Italy
  • Yuri E. Nikiforov
    Department of Pathology (M.G., Y.E.N.), University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15260

収録刊行物

被引用文献 (2)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ